「クリア」とはどういう意味ですか？
その動物は突然変異を持っていません。病気を発症することはありません そしてそれを伝えません。
犬 口蓋裂バリアント 2 (CP2)
The DNA test for Cleft Palate Variant 2 (CP2) in dogs is a crucial tool for breeders aiming to reduce the risk of this genetic disorder. CP2 is a hereditary condition that causes cleft palate, leading to feeding difficulties and respiratory issues in affected puppies. By identifying carriers through genetic testing, breeders can make informed mating decisions to prevent passing the mutation to offspring. This test is simple, accurate, and essential for maintaining healthy dog populations. Early detection of CP2 helps improve puppy survival rates and overall breed health. Investing in the CP2 DNA test supports responsible breeding practices and promotes the well-being of future generations. Ensure your breeding program includes CP2 screening to safeguard your dogs’ health.
略語 ： CP2
解析された変異: ADAMTS20 c.1358_1359del
継承 ： 常染色体劣性
頭字語
CP2
観測周波数
臨床的重症度
臨床分類
発達障害
解析された変異
ADAMTS20 c.1358_1359del
p.(K453Ifs*4)
p.(K453Ifs*4)
継承のモード
常染色体劣性
テストの概要:
The DNA test for Cleft Palate Variant 2 (CP2) in dogs helps identify genetic mutations linked to this congenital condition. CP2 causes an opening in the roof of the mouth, which can lead to feeding difficulties and respiratory issues. Early detection through genetic screening allows breeders to make informed decisions and reduce the risk of passing the trait to offspring. This test is especially important in breeds prone to cleft palate disorders. Overall, CP2 testing supports healthier breeding practices and improves puppy welfare.
パックから入手可能: Basic
この DNA 検査はパックから含まれています Basic — これもパックの一部です Basic, Standard, Advanced, Complete。
DNA テスト パックを見る →動物の繁殖戦略や健康戦略に最適なパックをお選びください。
Understanding Cleft Palate Variant 2 (CP2) in Dogs
Cleft Palate Variant 2 (CP2) is a genetic condition that affects the development of the palate in dogs. This condition is characterized by a failure of the hard and/or soft palate to fuse properly during embryonic development, resulting in an abnormal opening that can lead to various health complications. CP2 can significantly impact the quality of life for affected dogs, making early detection and management crucial.
Clinical Manifestations of CP2
Dogs with Cleft Palate Variant 2 may exhibit a range of clinical signs. Common symptoms include difficulty in feeding, nasal discharge, and an increased risk of aspiration pneumonia due to food or liquid entering the respiratory tract. Puppies with CP2 may struggle to gain weight and thrive, and they may require special feeding techniques or interventions to ensure adequate nutrition.
Genetic Basis of CP2
The genetic basis of Cleft Palate Variant 2 is linked to specific mutations that disrupt normal palatine development. Understanding the genetic factors associated with CP2 can help breeders make informed decisions when selecting breeding pairs, ultimately reducing the prevalence of this condition in future generations. The identification of these genetic markers is essential for advancing research and improving breeding practices.
Management and Treatment Options
Managing Cleft Palate Variant 2 often requires a multidisciplinary approach involving veterinarians, veterinary surgeons, and pet owners. Surgical intervention may be necessary to close the cleft and improve the dog's quality of life. In addition to surgical repair, affected dogs may need ongoing care, such as dietary modifications and regular veterinary check-ups, to monitor for potential complications.
Importance of Genetic Testing
Genetic testing for Cleft Palate Variant 2 is a valuable tool for breeders and pet owners. By identifying carriers of the CP2 gene, breeders can make more informed decisions to minimize the risk of producing affected puppies. Moreover, genetic testing can provide peace of mind for pet owners, allowing them to understand their dog's health status and take proactive measures if necessary.
結論
Cleft Palate Variant 2 (CP2) is a significant genetic condition that affects the oral and respiratory health of dogs. Through early detection, effective management, and responsible breeding practices informed by genetic testing, the impact of CP2 can be mitigated. Ongoing research into the genetic underpinnings of this condition will further enhance our understanding and ability to address it in canine populations.
試験に認められた品種: 口蓋裂バリアント 2 (CP2)
- Nova Scotia Duck Tolling Retriever
🧬 Interpretation of genotypes CP2
遺伝子型
状態
🟡 N/N
ノンキャリア - リスクなし
🟡 N/CP2
キャリア - リスクなし
❌ CP2/CP2
影響を受ける – 危険にさらされる
FAQ: 解釈を理解する
「キャリア」って本気なの？
いいえ、その動物は通常健康ですが、突然変異をその動物に伝える可能性があります。 子孫。
動物が「影響を受けている」場合はどうなりますか?
それは2つの突然変異したコピーを持っています。臨床症状は以下に応じて予想されます 病気。飼育してはいけません。
なぜ男性/女性で違いがあるのでしょうか？
一部の病気は性と関連があるため、その発現は性別によって異なります。 動物の性別。
子孫を予測する
N/N (%e3%83%8e%e3%83%b3%e3%82%ad%e3%83%a3%e3%83%aa%e3%82%a2）
N/CP2 (キャリア）
CP2/CP2 (影響を受ける）
DNA検査に関するよくある質問
この DNA 検査では何が検出されますか?
This DNA test detects the mutation associated with Cleft Palate Variant 2 (CP2) in order to identify clear, carrier, or at-risk animals.
なぜ繁殖動物を検査するのでしょうか?
DNA検査は、ブリーダーがより安全な交配を計画し、子孫に突然変異が伝わるリスクを軽減するのに役立ちます。
このテストの継承モードは何ですか?
このテストで報告される継承モードは常染色体劣性です。
このテストではどの変異が分析されますか?
This test analyses the mutation ADAMTS20 c.1358_1359del.
保菌動物は必ず影響を受けますか?
必ずしもそうとは限りません。解釈は、遺伝パターンと結果として生じる遺伝子型によって異なります。
参考文献
Wolf Zena T, Brand Harrison A, Shaffer John R, Leslie Elizabeth J, Arzi Boaz, Willet Cali E, Cox Timothy C, McHenry Toby, Narayan Nicole, Feingold Eleanor, Wang Xioajing, Sliskovic Saundra, Karmi Nili, Safra Noa, Sanchez Carla, Deleyiannis Frederic W B, Murray Jeffrey C, Wade Claire M, Marazita Mary L, Bannasch Danika L. Genome-wide association studies in dogs and humans identify ADAMTS20 as a risk variant for cleft lip and palate. PLoS Genet. 2015 Mar 23;11(3):e1005059. doi: 10.1371/journal.pgen.1005059. eCollection 2015 Mar.